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ABSTRACT 
BACKGROUND 
            Urbanization and deforestation has made snake bite an important public health 
problem. WHO’s inclusion of snake-bite envenoming in the list of category A as 
neglected tropical diseases in early 2009.  In India, snake bite takes a lot of human 
lives, and therefore warrant urgent attention. High mortality is due to poor rural health 
services and delay in initiating anti snake venom. It is estimated that there are over 
1,000,000 snakebites in India alone leading to between 45 000 and 50 000 deaths 
annually, although the figure is probably under-rated because most rural Indian 
population consults a traditional healers and so goes unreported. This study mainly 
focuses on the Prothrombin and activated Prothrombin Thromboplastin Time as an 
early marker for detection of snake bite, hematotoxicity as compared to Whole blood 
clotting time.   
 
PATIENTS AND METHODS 
              Retrospective cohort study done in Coimbatore Medical College and Hospital 
during the period Feb 2017 to Feb 2018, a total of 100 patients with history of snake 
bite and definitive bite marks present , presenting within 6 hours of snake bite were 
included in study. 
RESULTS               
             In the present study, maximum incidence of snake bite was found in the age of 
26-35 years comprising of 56%. 80% of the snake bite occurred in males attributed 
mainly to their outdoor activity compared to females.3%  of the snake bites were dry 
bite, haematotoxic (Viper bite), constituting to 97% of which 5% developed 
neurotoxicity (respiratory failure). Complications of hematotoxic bite were that 30% 
developed cellulitis, 7% developed renal failure, 13% developed both cellulitis and 
renal failure and the rest 10% developed other complications, which are more 
common complications of Russell”s Viper as seen in South India population. 26 % 
was identified as Russell’s Viper, where as 74% could not be identified as majority 
the bites occur in the dark 73%. Bleeding manifestation in the form of bleeding from 
bite site, mucosal bleed and gum bleed were seen in 8% of the study population. Thus 
hematotoxic snakebite it is now well recognized that such a strict categorization is not 
valid as each species can result in any kind of manifestations. 
                31 of the snake bite presented within 2 hours of bite, 41 within 2-4 hours 
and 28 within 4-6 hours, the delay in presentation was due to delay referral , delay in 
transportation and lack of awareness . 30% of patients received ASV within 2 hours of 
snake bite; 40% of patients within 2 to 4 hours, 27 % of patients in 4 to 6 hours, about 
3 % of patient did not required ASV, thus indicating Dry bite . 31 patients received 10 
vials of ASV .48 patients received 20 vials of ASV.18 patients received 30 vials of 
ASV. The mean ASV received by patient who presented at 0-2 hours of bite was11.6 
vials, 2-4 hours was 18.78 vials and 4-6 hours was 23.92 vials. Complications 
developed in patient presenting within 0-2 hours was 6.5%, within 2-4 hours was 
70.7% and within 4-6 hours was 85.7% . The mean duration of stay in hospital among 
patient who presented within 0-2 hours was 3.03 days, within 2-4 hours was 5 days 
and that of 4-6 hours was 7.42 days. Thus indicating that early initiation of ASV, 
decreases the amount of ASV requirement , decreases the complications and decreases 
the stay in hospital. 
Mortality rate in the study was 4 out of 100 which was in comparison with the 
national data 4.5 – 5 out of 100 deaths annually. 1 was a female and others 3 were 
male , the mean age was 42.75 years , all of the presented at 6 hours of bite with 
bleeding manifestation. 3 of them had renal failure and had to undergo dialysis. 3 had 
pre existing co morbidities. Mean ASV used was 30 vials and mean duration of stay in 
hospital was 12.5 days. 
64 % of study population had PT and aPTT alone prolongation, where majority 
of them presented with 3 hours of snake bite, i.e 54 out of 64. 26 % of study 
population had both PT & aPTT and WBCT prolongation , and 10 % had both the test 
as normal. Thus screening of patients with ProthrombinTime will help to detect 
coagulopathy earlier  so that antisnake venom (ASV)  can be administered earlier and 
further complications of coagulopathy can be prevented as well as number of vials of 
ASV given can be reduced in number. 
 
CONCLUSION  
Snake bite is a major health hazard in a tropical country like India being significantly 
associated with morbidity and mortality. 
Incidence of snake bite is more common in young males compared to females due to 
their more outdoor activity. 
Even if there is no evidence of envenomation, when they arrive patients should be 
admitted for observation, ideally for 24 hours. Every hourly symptoms of  
hematotoxicity, level of consciousness, ptosis, pulse rate and rhythm, blood pressure, 
respiratory rate, extent of local swelling should be recorded. 
Haematological abnormalities are very common in snake envenomation especially in 
viperidae bites. 
Manifestations like bite site bleeding, gum bleeding, hematuria, injection site bleeding 
are clinical indicators of hematotoxicity which can be prevented by earlier 
interventationwith anti-snake venom (ASV). 
Many guidelines described an abnormal 20 minute whole blood clotting test  as a 
marker of coagulation abnormality. However Prothrombin Time will be prolonged 
earlier compared to Whole Blood Clotting Test  and before clinical manifestations of 
hematotoxicity due to snake envenomation and is relatively more sensitive, but 
clotting time will be significantly prolonged in severe deficiencies of the various 
coagulation factors.  
So Prothrombin Time is a very useful blood investigation in making early diagnosis of 
Coagulopathy when managing hematotoxic snake bite cases compared to Whole 
Blood Clotting Test. 
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